Epilepsy in Children: The Impact of the Gut Microbiota and Epigenetics in Successful Dietary Treatment
Genetic mosaicism in focal epilepsy: Creating a platform for precision medicine in mosaic disorders
Pharmacokinetic interactions between ketogenic diet and anti-epileptic drugs in children
Long-term impact of dietary treatment in children and adolescents
Dietary treatment of adult patients with epilepsy
Epigenetics of epilepsy development
Epigenetics of juvenile myoclonic epilepsy
Clinical and molecular characterization of hereditary ataxia and hereditary spastic paraplegia
Translational pharmaco-omics: A system biology approach to identify underlying mechanisms of variation treatment response in neurological disease
Recent publications
Olstad EW, Nordeng HME, Sandve GK, Lyle R, Gervin K(2022) Low reliability of DNA methylation across Illumina Infinium platforms in cord blood: implications for replication studies and meta-analyses of prenatal exposures Clin Epigenetics, 14(1), 80 DOI 10.1186/s13148-022-01299-3, PubMed 35765087
Pedersen S, Kverneland M, Nakken KO, Rudi K, Iversen PO, Gervin K, Selmer KK(2022) Genome-wide decrease in DNA methylation in adults with epilepsy treated with modified ketogenic diet: A prospective study Epilepsia(in press) DOI 10.1111/epi.17351, PubMed 35762681
Absalom NL, Liao VWY, Johannesen KMH, Gardella E, Jacobs J, Lesca G, Gokce-Samar Z, Arzimanoglou A, Zeidler S, Striano P, Meyer P, Benkel-Herrenbrueck I, Mero IL, Rummel J, Chebib M, Møller RS, Ahring PK(2022) Gain-of-function and loss-of-function GABRB3 variants lead to distinct clinical phenotypes in patients with developmental and epileptic encephalopathies Nat Commun, 13(1), 1822 DOI 10.1038/s41467-022-29280-x, PubMed 35383156